Loading…

Ang-(1-7) promotes the migration and invasion of human renal cell carcinoma cells via Mas-mediated AKT signaling pathway

Ang-(1-7) is an active peptide component of renin-angiotensin system and endogenous ligand for Mas receptor. In the current study, we showed that Ang-(1-7) enhanced migratory and invasive abilities of renal cell carcinoma cells 786-O and Caki-1 by wound-healing, transwell migration and transwell inv...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications 2015-05, Vol.460 (2), p.333-340
Main Authors: Zheng, Shuai, Yang, Ying, Song, Ran, Yang, Xiaomei, Liu, Hua, Ma, Qian, Yang, Longyan, Meng, Ran, Tao, Tao, Wang, Songlin, He, Junqi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ang-(1-7) is an active peptide component of renin-angiotensin system and endogenous ligand for Mas receptor. In the current study, we showed that Ang-(1-7) enhanced migratory and invasive abilities of renal cell carcinoma cells 786-O and Caki-1 by wound-healing, transwell migration and transwell invasion assays. Mas antagonist A779 pretreatment or shRNA-mediated Mas knockdown abolished the stimulatory effect of Ang-(1-7). Furthermore, Ang-(1-7)-stimulated AKT activation was inhibited by either A779 pretreatment or Mas knockdown. Blockage of AKT signaling by AKT inhibitor VIII inhibited Ang-(1-7)-induced migration and invasion in 786-O cells. Taken together, our results provided the first evidence for the pro-metastatic role of Ang-(1-7) in RCC, which may help to better understand the molecular mechanism underlying the progression of this tumor. •Ang-(1-7) promotes migration and invasion in RCC cells 786-O and Caki-1.•Mas receptor mediates Ang-(1-7)-induced promotion of migration and invasion.•Ang-(1-7)/Mas-induced cell migration and invasion is dependent on AKT activation.
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2015.03.035